Edarbi 80 mg tablets (comparator)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Edarbi 80 mg tablets (comparator), covering 2025-05-25 to 2025-05-25. Get the full timeline:
Most recent: Clinical Trial Update: Bioequivalence Study of Azilsartan Medoxomil 80 mg Tablets (Gedeon Richter Plc., Hungary) and Edarbi® 80 mg Tablets (JSC Nizhpharm, Russia) [Phase 1]